Document:

Mary
Jane’s CBD Dispensary, Inc.

218
Dartmouth Drive SE

Albuquerque,
New Mexico 87106

 

 

Management
Agreement 

for

Romish
Mason Habib

 

THIS MANAGEMENT AGREEMENT
(this “Agreement”) is entered into effective as of the 5th day of May,, 2019, as a condition of my employment
with Mary Jane’s CBD Dispensary, Inc., a Nevada corporation, its subsidiaries, affiliates, successors or assigns (together
the "Company"), and in consideration of my employment with the Company and my receipt of the compensation now and hereafter
paid to me by Company.

 

1. Employment.
The Company hereby agrees to employ me as an Employee and I hereby agree to work for the Company upon the terms and conditions
set forth herein.

 

       2.
Term - I UNDERSTAND AND ACKNOWLEDGE THAT MY EMPLOYMENT WITH THE COMPANY IS FOR A PERIOD OF TWO (2) YEARS AND UNLESS OTHERWISE
EXTENDED, AND WILL Automatically RENEW FOR SUCCESSIVE ONE YEAR PERIODS UNLESS OTHERWISE
EXTENDED BY MUTUAL AGREEMENT OR TERMINATED BY EITHER PARTY WITH 30 DAYS WRITTEN NOTICE PRIOR TO THE EXPIRATION OF THE INITIAL TERM
OR ANY SUCCESSIVE TERM HEREUNDER. I ACKNOWLEDGE THAT OTHER THAN TERMINATION FOLLOWING THE INITIAL TERM, THAT THIS EMPLOYMENT RELATIONSHIP
MAY BE ONLY BE TERMINATED BY THE COMPANY FOR CAUSE OR BY ME AT ANY TIME UPON SIXTY (60) DAYS WRITTEN NOTICE.

 

3. Scope of Duties;
Representations and Warranties.

 

(a) I will have such duties
as are assigned or delegated to me by the Company’s Board of Directors, and will initially serve as the Chairman of the Board
of Directors and Chief Operating Officer of the Company. I will devote all necessary and reasonable business time, attention, skills,
and energy to the business of the Company and will use my best efforts to promote the success of the Company's business, and will
cooperate fully with its Board of Directors in the advancement of the best interests of the Company. Notwithstanding the forgoing,
I will continue to serve as a manager of certain other companies who may also have a pre-existing relationships with the Company
and I may continue to serve in these capacities, provided that it does not unreasonably interfere with the execution of my responsibilities
with the Company.

 

(b) I represent and warrant
that by my execution and delivery of this Agreement I do not, and the performance of my obligations hereunder will not, with or
without the giving of notice or the passage of time, or both: (i) violate any judgment, writ, injunction, or order of any court,
arbitrator, or governmental agency applicable to me, (ii) conflict with, result in the breach of any provisions of or the termination
of, or constitute a default under, any agreement to which I am a party or by which I am or may be bound.

 

(c) I understand that from
time to time the Company may engage and use professional employment organizations (“PEO’(s)”) to address its
human resources, payroll, insurance and other employment related needs. Many PEO’s use the term “co-employment,”
to describe the relationship between an employee on the one hand and the PEO and the PEO’s client on the other hand; in that
event I may be deemed to be an employee of the Company and the PEO. In the event that the Company elects to use a PEO or change
from one PEO to another, my employment with the Company will remain unchanged with respect to my obligations to the Company under
this agreement; and, in the event of any inconsistency or contradictory provision contained in any PEO agreement to which the Company
or I am a party, the terms of this Agreement shall control and supersede the terms of such other agreement..

 

    	 		 

    	 

    

 

4. Compensation.

 

(a) Base Compensation.
The Company shall initially pay me base compensation of Five Thousand Dollars ($5,000) per month. This initial compensation is
significantly below not only industry standards but specifically, it is well below my pervious compensation with other employers.
As of the date of this Agreement, the Company is planning to expand into a new line of business involving CBD and to increase its
operations significantly and rapidly which will require that it allocate capital for the costs and expenses associated with these
plans. The Company recognizes that this change in business focus was initiated at my suggestion and continues to believe that this
is the best use of its resources and that I am in the best position to help the Company realize its business objectives through
my skill sets and my various relationships that are required for success. However, the Company is not currently in the financial
position to provide compensation commensurate with my skills, experience and prior salary, but once the Company achieves certain
milestones, it will be in position to provide a higher base pay rate as well as provide certain bonuses as set forth herein.
I am willing to accept a relatively lower base salary initially, provided that if I am successful in delivering increased sales
and managing larger operations, that my base salary will be increased accordingly and; I will receive bonuses based upon the profitability
of the increased operations. Therefore, my initial base compensation will continue until the Company achieves Two Million Five
Hundred Thousand Dollars ($2.500,000.00) in annual sales, at which point, provided that the Company is profitable, my base salary
shall be increased to Ten Thousand Dollars ($10,000) per month. If, however, the Company’s sales have reached Two Million
Five Hundred Thousand Dollars ($2,500,000.00) but it is not profitable, the increase shall be made less thirty percent (30%). When
the Company reaches Five Million Dollars ($5,000,000.00) in annual sales, my base salary shall be increased to Twelve Thousand
Five Hundred Dollars ($12,500.00) per month; when annual sales reach Ten Million Dollars ($10,000,000.00) my base salary shall
be increased to Fifteen Thousand Dollars ($15,000.00) per month; when annual sales reach Twenty Five Million Dollars ($25,000,000.00)
my base salary shall be increased to Twenty Thousand Dollars ($20,000.00) per month; and when annual sales reach Forty Five Million
Dollars ($45,000,000.00) my base salary shall be increased to Thirty Thousand Dollars ($30,000.00) per month. In each of the forgoing
cases, the increases in salary shall be made provided that the Company is profitable and if not profitable, (recognizing that the
increase in revenues is vitally important to the Company’s success) the increases in salary shall be made as stated less
thirty percent (30%) at the level of increase at issue. Each sum is referred to as “base compensation,” will be payable
in equal periodic installments according to the Company's customary payroll practices, but no less frequently than bi-monthly,
subject to adjustment as provided below. My base compensation will be reviewed by the Board of Directors of the Company not less
frequently than annually, and may be adjusted upward or downward (but not lower than the amounts listed above, based on annual
gross sales) in the sole discretion of the management of the Company.

 

(b) Bonuses. During
the Term of my employment I will be eligible to receive bonuses based on the number of new stores opened and the profitability
of those stores. The purpose of these bonuses is to compensate and create an incentive for me to successfully meet the Company’s
business objectives.

 

(i) New Store Bonuses.
During the Initial Term of this Agreement and for each successive term thereafter, for each of the first 10 stores or kiosks that
the Company opens, I will receive a bonus of Three Thousand Dollars ($3,000.00) and thereafter for each store or kiosk that the
Company opens, I will receive a bonus of Five Thousand Dollars ($5,000.00). Further, in the event that the Company chooses to franchise
stores, for each store or kiosk franchise sold, I shall be entitled to receive the sum of Five Thousand Dollars ($5,000.00) from
the Company as a bonus provided that the Company has received payment from the franchisee. The bonus(s) payable shall be paid at
the end of each quarter or 90 days after the store is operational whichever is greater.

 

(ii) Bonuses Based
on Profitability. During the Initial Term of this Agreement and for each successive term thereafter, for each store or kiosk
that is opened, as to each location operating profitably, with margins of 40% or greater of EBITA, I shall be entitled to receive
a bonus equal to 2% of each store or kiosk’s gross revenue per quarter payable within 15 days of the end of each quarter
(less adjustments for returns and allowances.

 

    	 	2	 

    	 

    

 

(c) Grant of Common
Stock.

 

(i) Background.
When the Company was first purchased by Moses Campbell and Matthew Meyer, I had presented a basic business plan involving transitioning
sales to CBD products and ancillary products. Since beginning to follow my plan, it is now beginning to realize a significant increase
in revenue. However, the Company recognizes that it will require personnel with certain skill sets as well as relationships with
certain key individuals and entities in order to fully follow and implement that business plan. Messers. Campbell and Meyer, as
well as management of the Company now recognize that I have the skill sets necessary as well as the relationships that are needed
in order to continue with the aforementioned business plan; and that it is in their best interests as shareholders as well as in
the best interests of the other shareholders if I were to become a significant part of the Company; and specifically, a significant
equity holder of the Company. After significant negotiations with Mr. Campbell individually and on behalf of the Company, Mr. Campbell
agreed that he would return certain shares of the Company’s Common Stock he was holding and that shares could then be issued
to me without increasing the issued and outstanding shares overall.

 

(ii) Shares Granted
/ Cancelation of Certain Shares. As a condition to my employment, upon execution of the Agreement I shall be entitled to receive
an aggregate of Six Million Five Hundred Thousand Shares (6,500,000) of the Company’s Common Stock, $0.0001 par value. Concurrently
with the issuance of these shares, and as a further condition to my employment, Moses Campbell shall return to treasury, an equal
number of common shares, $0.0001 par value, or 6,500,000 shares for cancelation.

 

(iii) Stated Value
and Taxes. The Company and I each agree that the deemed value of the shares issuable to me is $6,500.00 and that I will be
responsible for filing with the Internal Revenue Service (“IRS”), a letter, duly making an election to be taxed on
the receipt of these shares as ordinary income under Section 83(b) of the Internal Revenue Code (“IRC”) at the deemed
value of $6,500.00 (the “83(b) Election.”)

 

(iv) Lock Up and Leak-Out.
I agree that I will refrain from selling any of the shares granted hereunder for a period of 18 months from that date of this Agreement.
Thereafter I agree that I will not sell more than the greater of: (1) 10,000 shares per day or (2) 10% of the daily volume. In
addition I will limit the total number of shares that I sell in any 90 day period to 1% of the total issued and outstanding shares
at any applicable time.

 

All payments of salary
and other compensation paid to me shall be made after deduction of any taxes and other amounts which are required to be withheld
with respect thereto under applicable federal and state laws.

 

(d) As additional consideration
under this Agreement, as an officer of Mary Jane’s CBD Dispensary, Inc., I will be eligible to receive stock options for
the purchase of shares of Mary Jane’s CBD Dispensary, Inc. Common Stock in the event that the Company institutes and adopts
a Stock Option Plan.

 

    	 	3	 

    	 

    

 

5. Fringe Benefits;
Expenses.

 

(a) So long as I am employed
by the Company, I will be eligible to participate in all employee benefit plans sponsored by the Company for its employees in accordance
with the Company’s policies, including but not limited to vacation policy, sick leave and disability leave, life insurance,
health insurance, dental insurance, and stock ownership and/or profit sharing plans; provided, however, that the nature, amount
and limitations of such plans shall be determined from time to time by the Board of Directors of the Company and/or the Compensation
Committee, to the extent such committee is established. I understand that by being eligible to participate in benefits such as
health insurance, dental insurance and life insurance, participation will be subject to employee contributions which may change
from time to time.

 

       (b)
The Company shall reimburse me for all approved reasonable business expenses incurred by me in the scope of my employment; provided,
however, that such expenses must be pre approved and I must file expense reports with respect to such expenses in accordance with
the Company's policies as are in effect from time to time.

 

(c) I am entitled to paid
vacation in accordance with the vacation policies of the Company in effect from time to time. I will also be entitled to the paid
holidays and other paid leave set forth in the Company's policies.

 

6. Termination.
I agree that my employment may be terminated by the Company with "Cause," subject to the terms of this Section 6. If
I am terminated without Cause, I will be entitled to the severance provisions of Section 6(c). Such termination shall be effective
upon delivery of written notice to me of the Company's election to terminate my employment under this Section 6.

 

(a) Definition of "Cause".
When used in connection with the termination of employment with the Company, "Cause" shall mean: (i) the conviction of
or the entering of a guilty plea or plea of no contest with respect to, a felony, the equivalent thereof, or any other crime which
results in my imprisonment; (ii) the commission by me of an act of fraud upon the Company or any of its affiliates; (iii) the misappropriation
(or attempted misappropriation) of any funds or property of the Company or any of its affiliates by me; (iv) my engagement in any
direct, material conflict of interest with the Company without compliance with the Company's conflict of interest policy, if any,
then in effect; (v) my engagement, without the written approval of the Board of Directors of the Company, in any activity which
competes with the business of the Company or any of its affiliates or which would result in a material injury to the Company or
any of its affiliates; (vi) my failure to sign any lock-up letters, standstill agreements, or other similar documentation required
by an underwriter in connection with an offering or listing of securities by the Company or failure to take other actions reasonably
related thereto as requested by the Board of Directors of the Company; or (vii) for the Company’s poor financial performance,
directly caused by my management, strategies or policies, provided however that the determination must be reasonable in finding
“poor financial performance” and its cause; and any such findings must also be made in good faith by the Board of Directors
taking into consideration, the totality of the circumstances.

 

       (b)
Termination for Cause or Resignation. If the Company terminates my employment for Cause or if I voluntarily resign, the
Company shall pay any salary including any bonuses earned through the date of termination, but all rights to any other compensation
(except stock or option grants if vested) or benefits arising hereunder shall be canceled and terminated in all respects concurrently
with such termination of employment; provided that I may elect to continue to participate, at my own expense, in such health insurance
and other benefits as to which the opportunity for continuing participation is mandated by applicable law.

 

    	 	4	 

    	 

    

 

       (c)
Termination Without Cause or Wrongful Termination. In the event that my employment is terminated by the Company without
Cause, the Company shall, subject to the terms of subsections (d) and (e) of this Section 6 below, and only if and as long as I
am not in breach of my obligations under this Agreement, (i) pay to me, the greater of: (i)an amount equal to the sum of all salary
and bonuses due through the end of the Term, then in effect or (ii) an amount equal to two (2) years compensation at my then current
salary payable together with bonuses that would have been payable for that period, in either case in one lump sum, and (ii) continue
to provide benefits in the kind and amounts provided up to the date of termination for such two (2) year or longer period, including
continuation of any Company-paid benefits as described in Section 5, for me and my family. Further, in the event that the Company
wrongfully terminates my employment, purportedly for cause, subject to subsections (d) and (e) of this Section 6 below, the Company
shall pay to me, as liquidated damages and not as a penalty (it being acknowledged that it would be extremely difficult to determine
not just the actual financial harm done but the extent and depth that the impact such a wrongful termination would have on my career
prospects and future opportunities), an amount equal to five (5) years compensation at my then current salary payable together
with bonuses that would have been payable for that five (5) year period, in one lump sum, payable regardless of any claims or off-sets
that the Company may have against me; and continue to provide benefits in the kind and amounts provided up to the date of such
wrongful termination for such five (5) year or longer period, including continuation of any Company-paid benefits as described
in Section 5, for me and my family.

 

(d) Disability; Death.
If at any time during the term of this Agreement, I am unable due to physical or mental disability to perform effectively my duties
hereunder, the Company shall continue payment of compensation as provided in Section 4 during the six (6) months of such disability
to the extent not covered by the Company's disability insurance policies. Upon the expiration of such six (6) month period, the
Company, at its sole option, may continue payment of my salary or wages for such additional periods as the Company elects, or may
terminate this Agreement without further obligations hereunder. If I should die during the term of this Agreement, my employment
and the Company's obligations hereunder shall terminate as of the day that my death occurs and there will be no salary, wages and
benefit continuation period.

 

(e) Securities Matters.
I agree that I will sign any lock-up letters, standstill agreements, or other similar documentation required by an underwriter
in connection with a public offering of securities by the Company or take other actions reasonably related thereto as requested
by the Board of Directors of the Company. Failure to take any such action shall be "Cause" for termination, or if termination
has already occurred, shall cause me to forfeit any further rights to the salary or wage continuation or other payments that would
otherwise be payable to me. In addition, I agree that in such event the Company can seek and obtain specific performance of such
covenant, including any injunction requiring execution of such documents and the taking of such actions, and I hereby appoint the
then current president of the Company to sign any such documents on my behalf so long as such documents are prepared on the same
basis as other management shareholders generally.

 

(f) Waiver and Release.
In the event that my employment is terminated by the Company without Cause, I agree to accept, in full settlement of any and all
claims, losses, damages and other demands which I may have arising out of such termination, as liquidated damages and not as a
penalty, the applicable amounts payable to me as set forth in this Section 6. I hereby waive any and all rights I may have to bring
any cause of action or proceeding contesting any termination without Cause. Under no circumstances shall I be entitled to any compensation
or confirmation of any benefits under this Agreement for any period of time following my date of termination if my termination
is for Cause.

 

    	 	5	 

    	 

    

 

7. Confidential Information.

 

(a) Company Information.
I agree at all times during the term of my employment and thereafter, to hold in strictest confidence, and not to use, except for
the benefit of the Company, or to disclose to any person, firm or corporation without written authorization of the Board of Directors
of the Company, any Confidential Information of the Company. I understand that "Confidential Information" means any Company
proprietary information, technical data, trade secrets or know-how, including, but not limited to, research and development, product
plans, products, services, information regarding the skills and compensation of employees of the Company; the identity of the Company’s
clients, potential clients, customers and potential customers (hereinafter referred to collectively as “Customers”),
the particular preferences, likes, dislikes and needs of those Customers; Customer information regarding contact persons, pricing,
sales calls, timing, sales terms, and service plans; methods, practices, strategies, forecasts, and other marketing techniques;
the identities of key accounts and potential key accounts; the identities of the Company’s suppliers, independent contractors
and consultants, and information regarding contact persons, pricing, sales calls, timing, sales terms, and service plans; methods,
practices, strategies, forecasts, and other techniques of the forgoing; markets, software, developments, inventions, processes,
formulas, technology, designs, drawings, engineering, hardware configuration information, marketing, finances or other business
information, strategy and cost data; disclosed to me by the Company either directly or indirectly in writing, orally or by drawings
or observation of parts or equipment. I further understand that Confidential Information does not include any of the foregoing
items which have become publicly known and made generally available through no direct or indirect wrongful act of mine or others
who were under confidentiality obligations as to the item or items involved. Further Confidential Information does not include
information that is required to be disclosed by order of a governmental agency or by a court of competent jurisdiction.

 

(b) Third Party Information.
I recognize that the Company has received and in the future will receive from third parties their confidential or proprietary information
subject to a duty on the Company's part to maintain the confidentiality of such information and to use it only for certain limited
purposes. I agree to hold all such confidential or proprietary information in the strictest confidence and not to disclose it to
any person, firm or corporation or to use it except as necessary in carrying out my work for the Company consistent with the Company's
agreement with such third party.

 

(c) Continuing Obligations.
The obligations of this Section 7 shall survive the expiration or Termination of this Agreement.

 

8. Inventions.

 

(a) Inventions Retained
and Licensed. I have attached hereto, as Exhibit A, a list describing all inventions, original works of authorship, developments,
improvements, and trade secrets which were made by me prior to my employment with the Company (collectively referred to as "Prior
Inventions"), which belong to me and which are not assigned to the Company hereunder; or, if no such list is attached, I represent
that there are no such Prior Inventions. If in the course of my employment with the Company, I incorporate into a Company product,
process or technology a Prior Invention owned by me or in which I have an interest, the Company is hereby granted and shall have
a nonexclusive, royalty-free, irrevocable, perpetual, worldwide license to make, have made, modify, use and sell such Prior Invention
as part of or in connection with such product, process or machine.

 

(b) Assignment of Inventions
and other Intellectual Property. I agree that I will promptly make full written disclosure to the Company, will hold in trust
for the sole right and benefit of the Company, and hereby assign to the Company, or its designee, all my right, title, and interest
in and to any and all inventions, original works of authorship, developments, concepts, improvements or trade secrets, whether
or not patentable or registrable under copyright, patent or similar laws, which I may solely or jointly conceive or develop or
reduce to practice, or cause to be conceived or developed or reduced to practice which relate in any way to any Company Products,
defined below, including but not limited to the methods, designs or processes, together with the zone of foreseeable expansion,
during the period of time I am in the employ of the Company (collectively referred to as "Inventions"). I further acknowledge
that all original works of authorship which are made by me (solely or jointly with others) within the scope of and during the period
of my employment with the Company and which are protectible by copyright are "works made for hire," as that term is defined
in the United States Copyright Act.

 

    	 	6	 

    	 

    

 

(c) Maintenance of Records.
I agree to keep and maintain adequate and current written records of all Inventions made by me (solely or jointly with others)
during the term of my employment with the Company. The records will be in the form of notes, sketches, drawings, and any other
format that may be specified by the Company. The records will be available to and remain the sole property of the Company at all
times.

 

(d) Patent and Copyright
Registrations. I agree to assist the Company, or its designee, at the Company's expense, in every proper way to secure the
Company's rights in the Inventions and any copyrights, patents, mask work rights or other intellectual property rights relating
thereto in any and all countries, including the disclosure of the Company of all pertinent information and data with respect thereto,
the execution of all applications, specifications, oaths, assignments and all other instruments which the Company shall deem necessary
in order to apply for and obtain such rights and in order to assign and convey to the Company, its successors, assigns, and nominees
the sole and exclusive rights, title and interest in and to such Inventions, and any copyrights, patents, mask work rights or other
intellectual property rights relating thereto. I further agree that my obligation to execute or cause to be executed, when it is
in my power to do so, any such instrument or papers shall continue after the termination of this Agreement. If the Company is unable
because of my mental or physical incapacity or for any other reason to secure my signature to apply for or to pursue any application
of any United States or foreign patents or copyright registrations covering Inventions or original works of authorship assigned
to the Company as above, then I hereby irrevocably designate and appoint the Company and its duly authorized officers and agents
as my agent and attorney in fact, to act for and in my behalf and stead to execute and file any such applications and to do all
other lawfully permitted acts to further the prosecution and issuance of letters patent or copyright registrations thereon with
the same legal force and effect as if executed by me.

 

9. Covenant Not to Compete,
Non-Solicitation.

(a)         
Non Competition and Non Solicitation: I agree that beginning with the effective date
of this Agreement and continuing for a period of two (2) years after the termination of my employment, I will not alone, or in
any capacity with another entity or individual, within the United States of America and its territories and any other country where
the Company, at the date of the termination of my employment, has engaged or has plans to engage in any business:

(i.) directly or indirectly
participate or support in any capacity (e.g. as an advisor, principal agent, partner, member, governor, officer, director, manager,
shareholder, owner, employee or otherwise) the design, development, manufacture, sale, solicitation of sale, marketing, testing,
research, or other business activities for CBD or hemp oil and any product or product line involving CBD or hemp oil developed,
manufactured, marketed or sold by anyone other than the Company that treats, performs, addresses the same or substantially similar
processes, procedures or markets as a Company Product as defined herein. “Company Product” means any actual or projected
product, product line or service that has been designed; developed (or is under active development), manufactured, marketed or
sold by the Company continuing through the termination of my employment. Such Company Products shall include but not be limited
to oils, edibles, candies, vaping liquids, tablets, capsules, liquid gel caps, powders, tinctures, beverages, shots, etc. together
with anything in the zone of foreseeable expansion.

ii.) call upon, solicit,
contact or serve any of the then-existing customers, vendors or suppliers that have had a relationship with the Company during
the preceding twenty four (24) months, or any potential customers, vendors or suppliers that were solicited by the Company during
the preceding twenty four (24) months in connection with a product or service that competes with a Company Product;

    	 	7	 

    	 

    

 

iii.) disrupt, damage
or impair (or attempt to do the same) with the business of the Company whether by way of interfering with or disrupting the Company’s
relationship with its employees, customers, agents, representatives or vendors, or

iv.) employ or attempt
to employ (by assisting anyone else in the solicitation of) any of the Company’s current employees on behalf of any other
entity or person, whether or not such entity or person competes with the Company or any Company Product.

(b) I agree that the limitations
set forth herein on my rights to compete with the Company and its affiliates are reasonable and necessary for the protection of
the Company and its affiliates. In this regard, I specifically agree that the limitations as to period of time and geographic area,
as well as all other restrictions on my activities specified herein, are reasonable and necessary for the protection of the Company
and its affiliates. In this regard I specifically acknowledge that, given the narrow scope of the Company’s operations of
the Company Products, it is difficult to limit the forgoing, therefore the limitations set forth herein should be construed as
widely as possible. I agree that, in the event that the provisions of this Agreement should ever be deemed to exceed the scope
of business, time or geographic limitations permitted by applicable law, such provisions shall be and are hereby reformed to the
maximum scope of business, time or geographic limitations permitted by applicable law.

 

(c) I agree that the remedy
at law for any breach by me of this Section 9 will be inadequate and that the Company shall also be entitled to injunctive relief
without the necessity of posting any bond or other security, due to irreparable harm that such breach would cause.

 

10. Returning Company
Documents. I agree that, at the time of leaving the employ of the Company, I will deliver to the Company (and will not keep
in my possession, recreate or deliver to anyone else) any and all devices, records, data, notes, formulas, mixing instructions,
reports, proposals, lists, correspondence, specifications, drawings, blueprints, sketches, materials, equipment, other documents
or property, or reproductions of any aforementioned items developed, sold or worked with by me pursuant to my employment with the
Company or otherwise belonging to the Company it ssuccessors or assigns.

 

11. Notification of New
Employer. In the event that I leave the employ of the Company, I hereby grant consent to notification by the Company to my
new employer about my rights and obligations under this Agreement.

 

12. Representations.
I agree to execute any proper oath or verify any proper document required to carry out the terms of this Agreement. I represent
that my performance of all the terms of this Agreement will not breach any agreement to keep in confidence proprietary information
acquired by me in confidence or in trust prior to my employment by the Company. I have not entered into, and I agree I will not
enter into, any oral or written agreement in conflict herewith.

 

    	 	8	 

    	 

    

 

13. Indemnification.

 

(a)               
Certain Definitions. In the provision of indemnification benefits to Employee the Company
agrees that it shall be responsible to Employee for the performance under this Section 13. As used in this Section 13, the following
defined terms have the meanings indicated below:

“Claim”
means any threatened, pending or completed action, suit or proceeding (whether civil, criminal, administrative, formal or informal
investigative or other), whether instituted by or against the Company, its shareholders or any other person, or any inquiry or
investigation that the Employee in good faith believes might lead to the institution of any such action, suit or proceeding.

“Expenses”
means all attorneys’ fees and all other fees, costs, expenses and obligations paid or incurred in connection with investigating,
defending or participating (as a party, witness or otherwise) in (including on appeal), or preparing to defend or participate in,
any Claim relating to any Indemnifiable Event (as defined below), including the costs and expenses of the Employee seeking enforcement
of the provisions of this Section 13.

“Indemnifiable
Event” means any event or occurrence relating to or directly or indirectly arising out of, or any action taken or omitted
to be taken in connection with the provision of, (1) the services provided under this Agreement, (2) the Employee’s
rendering of advice to the Company or any shareholder or investor, (3) the Employee’s association with the Company or
any party with whom the Company has entered into or proposed to enter into any transaction or (4) any related matters.

“Loss”
means any and all damages, judgments, fines, penalties, amounts paid or payable in settlement, deficiencies, losses and Expenses
(including all interest, assessments, and other charges paid or payable in connection with or in respect of such Losses).

(b)              
Indemnification.

(i)                
In the event the Employee, in connection with his provision of the services under this Agreement
or his association with the Company, is or becomes a party to or other participant in, or is threatened to be made a party to or
other participant in, a Claim by reason of (or arising or allegedly arising in any manner out of or relating to in whole or in
part) an Indemnifiable Event or the Employee’s provision of the services, the Company, to the fullest extent permitted by
applicable law, shall indemnify and hold harmless, the Employee from and against any and all Losses suffered, incurred or sustained
by the Employee or to which the Employee becomes subject, resulting from, arising out of or relating to such Claim (it being understood
that except as provided in Section 13(b)(iii) below with respect to Expenses, reimbursements of any such Losses shall be made as
soon as practicable but in any event no later than 7 days after written request (a “Claim Notice”) is made to
the Company accompanied by supporting documentation). The Employee shall give the Company written notice of any Claim (accompanied
by such reasonable supporting documentation as may be in the Employee’s possession) as soon as practicable after the Employee
becomes aware thereof; provided, that the failure of the Employee to give such notice shall not relieve the Company of its
indemnification obligations under this Agreement, except to the extent that such failure materially prejudices the rights of the
Company.

(ii)              
In the event of any claim against the Employee, the indemnification procedures shall be conducted
in accordance with the following:

1.       Notification.
The Employee shall promptly notify the Company upon commencement of a proceeding for which the Employee intends to seek indemnification
against damages, and/or advancement of expenses. Failure to notify the Company will not relieve the Company from its obligations,
if any, to indemnify, and advance expenses of, the Employee with regard to any liabilities incurred and expenses paid prior to
such notification unless, and then only to the extent that, the Company has been damaged by such delay in notification.

    	 	9	 

    	 

    

 

2.       Assumption
of Defense. The Company may, alone or jointly with any other indemnifying party, assume the defense of a proceeding for which
the Company received notice, and shall promptly notify the Employee as to whether the Company will assume such defense. If the
Company assumes such defense, the Company will not be liable to the Employee for any expenses subsequently incurred by the Employee
in connection with the defense of such proceeding unless the Employee shall have reasonably concluded that there is a conflict
of interest between the Company, on the one hand and the Employee, on the other (or between the Employee and one or more other
indemnitees whose defense has been assumed by the Company), in the conduct of the defense of the proceeding, and such conclusion
is supported by an opinion of counsel experienced in the defense of litigation against corporate directors and officers, which
counsel and opinion shall be satisfactory to the Company and / or its legal counsel.

3.       Approval
of Employee’s Counsel. In the event the Company doesn’t assume the defense of the proceeding, the Employee may
engage legal counsel to conduct such defense. In such event the Company shall have the right to approve the Employee’s choice
of counsel and the terms of engagement of such counsel, which approval shall not be unreasonably withheld. With respect to its
approval, the Company may consider:

(A)       Whether
the Employee is cooperating in the selection of counsel with the Company and other indemnitees so that all indemnitees are represented
by one law firm except to the extent Paragraph 2 regarding conflicts of interest is applicable and satisfied;

(B)       The
experience of such counsel in similar matters;

(C)       The
financial arrangements with such counsel; and

(D)       To
the extent the Company has obtained insurance applicable to such proceeding, whether such insurance company has consented to the
Employee’s choice of counsel and the terms of engagement of such counsel.

 

4.       Settlements.
The Company shall not be liable to indemnify Employee for any amounts paid in settlement of any proceeding effected without the
Company’s prior written consent. The Company nor shall not settle any action or claim in any manner which would impose any
non-indemnified penalty, limitation, expense or liability on the Employee without the Employee’s prior written consent. Neither
the Company nor the Employee will unreasonably withhold their consent to any proposed settlement.

5.       Right
to Counsel. With respect to any proceeding as to which the Company has not assumed the defense, the Company may engage their
own counsel, at its expense, to assist in the defense of such proceeding. With respect to any proceeding as to which the Company
has assumed the defense, the Employee may engage his own counsel at his own expense, to assist in the defense of the proceeding.

(iii)            
The Employee’s right to indemnification in this Section 13 shall include the right
of the Employee to be advanced by the Company any Expenses incurred in connection with any Indemnifiable Event as such expenses
are incurred by the Employee; provided, however, that all amounts advanced in respect of such Expenses shall be
repaid to the Company by the Employee if it shall ultimately be determined in a final judgment by clear and convincing evidence
that the Employee is not entitled to be indemnified for such Expenses.

    	 	10	 

    	 

    

 

(c)               
Partial Indemnity, Etc. If the Employee is entitled under any provision of this Agreement
to indemnification by the Company for some or a portion of any Loss, but not for all of the total amount thereof, the Company shall
nevertheless indemnify the Employee for the portion thereof to which the Employee is entitled. Moreover, notwithstanding any other
provision of this Agreement, to the extent that the Employee has been successful on the merits or otherwise in defense of any or
all Claims relating in whole or in part to an Indemnifiable Event or in defense of any issue or matter therein, including dismissal
without prejudice, the Employee shall be indemnified against all Expenses incurred in connection therewith.

(d)              
No Presumptions. For purposes of this Agreement, the termination of any claim, action,
suit or proceeding, by judgment, order, settlement (whether with or without court approval), or upon a plea of nolo contendere,
or its equivalent, shall not create a presumption that the Employee did not meet any particular standard of conduct or have any
particular belief or that a court has determined that indemnification is not permitted by applicable law.

(e)               
Nonexclusivity, Etc. The rights of the Employee hereunder shall be in addition to any
other rights the Employee may have under any by-law, insurance policy, law of the State of Texas, the common law, or otherwise.
To the extent that a change in applicable law (whether by statute or judicial decision) would permit greater indemnification by
agreement than would be afforded currently under this Agreement, it is the intent of the parties hereto that the Employee shall
enjoy by this Agreement the greater benefits so afforded by such change.

(f)               
Subrogation. In the event of payment under this Agreement, the Company shall be subrogated
to the extent of such payment to all of the rights of recovery of the Employee and the Employee shall execute all papers required
and shall do everything that may be necessary to secure such rights, including the execution of such documents necessary to enable
the Company effectively to bring suit to enforce such rights.

(g)               
No Duplication of Payments. The Company shall not be liable under this Agreement to
make any payment in connection with the Claim made against the Employee to the extent the Employee has otherwise actually received
payment (under any insurance policy, by-law or otherwise) of the amounts otherwise indemnifiable hereunder, provided, that
if the Employee for any reason is required to disgorge any payment actually received by him, the Company shall be obligated to
pay such amount to the Employee in accordance with the other terms of this Agreement (i.e., disregarding the terms of this Section
13(g)).

14. 
General Provisions. 

 

(a) Governing Law; and
Venue. This Agreement shall be construed and interpreted in accordance with the laws of the State of Texas without reference
to principles of conflicts of laws. The parties agree that all actions or proceedings arising in connection with this Agreement
shall be tried and litigated only in the State or Federal Courts located in Texas. Each of the parties hereto waives to the extent
permitted under applicable law, any right each may have to assert the doctrine of forum non-conveniens or to object to venue to
the extend any proceeding is brought in accordance with this section relating to this Agreement.

 

(b) Entire Agreement.
This Agreement sets forth the entire agreement and understanding between the Company and me relating to the subject matter herein
and merges all prior discussions between us. No modification of or amendment to this Agreement, nor any waiver of any rights under
this agreement, will be effective unless in writing signed by the party to be charged. Any subsequent change or changes in duties,
salary or compensation will not affect the validity or scope of this Agreement.

 

    	 	11	 

    	 

    

 

(c) Severability.
If one more of the provisions in this Agreement are deemed void by law, then the remaining provisions will continue in full force
and effect.

 

(d) Successors and Assigns.
This Agreement will be binding upon me, my heirs, executors, administrators and other legal representatives and will be for the
benefit of the Company, its successors, and its assigns.

 

(e) Waiver and Amendments; Cumulative
Rights and Remedies.

 

(i.) This Agreement
may be amended, modified or supplemented, and any obligation hereunder may be waived, only by a written instrument executed by
the parties hereto. The waiver by either party of a breach of any provision of this Agreement shall not operate as a waiver of
any subsequent breach.

 

(ii.) No failure
on the part of any party to exercise, and no delay in exercising, any right or remedy hereunder shall operate as a waiver hereof,
nor shall any single or partial exercise of any such right or remedy by such party preclude any other or further exercise thereof
or the exercise of any other right or remedy. All rights and remedies hereunder are cumulative and are in addition to all other
rights and remedies provided by law, agreement or otherwise.

 

iii.) The Employee's
obligations to the Company and the Company's rights and remedies hereunder are in addition to all other obligations of the Employee
and rights and remedies of the Company created pursuant to any other agreement.

 

(f) Construction.
Each party to this Agreement has had the opportunity to review this Agreement with legal counsel. This Agreement shall not be construed
or interpreted against any party on the basis that such party drafted or authored a particular provision, parts of or the entirety
of this Agreement.

 

	 

Employee

	 	 
	Romish Mason Habib	 	Agreed and Accepted by the Board of Directors:
	 	 	Moses Campbell
	Signature	 	 
	 	 	Signature
	Company	 	 
	Mary Jane’s CBD Dispensary, Inc.	 	Matthew
Meyer
	 	 	 
	 	 	 
	Moses Campbell, CEO	 	Signature

 

    	 	12	 

    	 

    

 

EXHIBIT A

 

LIST OF PRIOR INVENTIONS

AND ORIGINAL WORKS OF AUTHORSHIP

 

	Title 	Date	Identifying or Brief Description	 	Number
	 	 	 	 	 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

___X___ No inventions or improvements

 

_______ Additional Sheets Attached

 

 

_____________________________

Signature of Employee:

 

_____________________________

Print Name of Employee:

 

    	 	13	 

    	 

    

 

Exhibit B

To Employment Agreement by and between Romish
Mason Habib

and 

Mary Jane’s CBD Dispensary, Inc.

dated May 5th 2019

 

INDEMNIFICATION PROCEDURES

 

 

1.       Notification.
An Indemnitee shall promptly notify an Indemnitor upon commencement of a Proceeding for which the Indemnitee intends to seek indemnification
against Damages, and/or advancement of expenses from the Indemnitor. Failure to notify the Indemnitor will not relieve the Indemnitor
from Indemnitor’s obligations, if any, to indemnify, and advance expenses of, the Indemnitee with regard to any liabilities
incurred and expenses paid prior to such notification unless, and then only to the extent that, the Indemnitor has been damaged
by such delay in notification.

2.       Assumption
of Defense. The Indemnitor may, alone or jointly with any other indemnifying party, assume the defense of a Proceeding for
which the Indemnitor received notice or otherwise, and shall promptly notify the Indemnitee as to whether the Indemnitor will assume
such defense. If the Indemnitor assumes such defense, the Indemnitor will not be liable to the Indemnitee for any expenses subsequently
incurred by the Indemnitee in connection with the defense of such Proceeding unless the Indemnitee shall have reasonably concluded
that there is a conflict of interest between the Indemnitor and the Indemnitee (or between the Indemnitee and one or more other
Indemnitees whose defense has been assumed by the Indemnitor), in the conduct of the defense of the Proceeding, and such conclusion
is supported by an opinion of counsel experienced in the defense of litigation against corporate directors and officers, which
counsel and opinion shall be satisfactory to the Indemnitor and its legal counsel.

3.       Approval
of Indemnitee’s Counsel. In the event the Indemnitor doesn’t assume the defense of the Proceeding, the Indemnitee
may engage legal counsel to conduct such defense. In such event the Indemnitor shall have the right to approve the Indemnitee’s
choice of counsel and the terms of engagement of such counsel, which approval shall not be unreasonably withheld. With respect
to its approval, the Indemnitor may consider:

(a)       Whether
the Indemnitee is cooperating in the selection of counsel with the Indemnitor and other Indemnitees so that all Indemnitees are
represented by one law firm except to the extent Paragraph 2 regarding conflicts of interest is applicable and satisfied;

 

(b)       The
experience of such counsel in similar matters;

 

(c)       The
financial arrangements with such counsel; and

 

(d)       To
the extent the Indemnitor has obtained insurance applicable to such Proceeding, whether such insurance company has consented to
the Indemnitee’s choice of counsel and the terms of engagement of such counsel.

 

    	 	14	 

    	 

    

 

4.       Settlements.
The Indemnitor shall not be liable to indemnify any Indemnitee for any amounts paid in settlement of any Proceeding effected without
the Indemnitor’s prior written consent. The Indemnitor shall not settle any action or claim in any manner which would impose
any non-indemnified penalty, limitation, expense or liability on an Indemnitee without the Indemnitee’s prior written consent.
Neither the Indemnitor nor the Indemnitee will unreasonably withhold their consent to any proposed settlement.

5.       Right
to Counsel. With respect to any Proceeding as to which the Indemnitor has not assumed the defense, the Indemnitor may engage
its own counsel, at its expense, to assist in the defense of such Proceeding. With respect to any Proceeding as to which the Indemnitor
has assumed the defense, the Indemnitee may engage his, her, or its own counsel, at his, her, or its own expense, to assist in
the defense of the Proceeding.

6.       Effect
on Statutory Requirements; Definitions.

(a)       The
limitations set forth in these Indemnification Procedures shall be in addition to the statutory standards for indemnification and
advancement of expenses set forth in the Nevada Act.

(b)       “Indemnitee”
means any person who is or may be eligible for indemnification or advancement of expenses by the Indemnitor pursuant to Section
13 of that certain Employment Agreement by and between Romish Mason Habib and Mary Jane’s CBD Dispensary, Inc., a Nevada
corporation dated May 5th, 2019 (the “Agreement”) and includes, if applicable, such Indemnitee’s estate,
spouse, legal representative, successor or assigns of the Agreement.

 

(c)       “Proceeding”
means any action, claim, suit, inquiry, investigation, court or administrative or arbitration proceeding brought by a party other
than an Indemnitee against an indemnitor, or appeal taken from any of the foregoing, by or before any court, governmental authority,
arbitrator or arbitration panel, whether pending or threatened.

 

(d)       “Damages”
means any costs, expenses, fines, judgments, settlements, penalties or other monetary amounts incurred in connection with a Proceeding.

 

    	 	15EX-10.1

 [*] = Certain confidential information contained in this document, marked by brackets, is omitted because
it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. 
 Exhibit 10.1 

PROCESSING AGREEMENT 

THIS PROCESSING AGREEMENT (“Agreement”) is made on January 1, 2019 (the “Effective Date”) between Isomedix Operations
Inc., including its affiliates, Isomedix Corporation, STERIS Isomedix Puerto Rico, Inc., and Synergy Health AST, LLC (“STERIS”), with headquarters at 5960 Heisley Road, Mentor, Ohio 44060, and Intersect ENT, Inc. (“Customer”),
having a principal place of business at 1555 Adams Drive, Menlo Park, California 94025. 
 WHEREAS, Customer seeks to have certain of its
ear, nose, and throat devices (Customer’s “Product” or “Products”), processed with radiation and STERIS is in the business of operating various radiation processing facilities (the “Facilities”); and 

WHEREAS, the Food and Drug Administration (“FDA”) has recognized that it is a common industry practice to manufacture and/or
assemble, package and fully label a device as sterile at one establishment and then ship such device in interstate commerce to another establishment or to a contract sterilizer for processing; and 

WHEREAS, the FDA will institute no regulatory action against the device as misbranded or adulterated during such shipment when the device is
labeled sterile, provided the requirements of 21 C.F.R. § 801.150 are met. 
 NOW THEREFORE, in consideration of the agreements
hereinafter set forth, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows: 

1. INTENT OF THE PARTIES. It is the intention of the parties hereto to adhere to all of the requirements of the FDA, including 21
C.F.R. § 801.150. 
 2. PRODUCT HANDLING. 

(a) Both Customer and STERIS acknowledge that Products transported from Customer to STERIS pursuant to this Agreement are non-sterile and are being shipped for further processing by STERIS. 
 (b) All Products shipped by
Customer to STERIS shall be conspicuously marked “Non-Sterile – Shipped for Further Processing” or the equivalent and shall not be identified as sterile until the Products are established as
sterile after treatment by methods specified by the Customer. The provisions of this paragraph shall apply during all times when the Product is introduced into or moving in intrastate or interstate commerce, during processing, and when held in
quarantine. 

  
 1 

 (c) Each shipment of the Product for processing will be accompanied by documents (packing
list and/or bill of lading) stating the number of cartons or other designated units in the shipment listed by manufacturer’s lot and code number and the non-sterile nature of the Product. Upon receipt and
prior to processing, STERIS will record on its receiving documents the number of cartons or other designated units by manufacturer’s lot and code number received from Customer. STERIS will notify Customer of all count discrepancies and the
parties shall ensure that all such discrepancies are reconciled before processing. 
 (d) STERIS will segregate unprocessed Products and
Products designated as nonconforming or processed incorrectly (i.e., those processed not in accordance to specifications such as Product that received incorrect sterilization dose) from processed Products, to prevent accidental mixing of Products.
STERIS will also segregate Customer’s Products from all other products stored at the STERIS Facility. 
 (e) After completion of
processing and until released by the Customer, the Product will be conspicuously marked by STERIS in the following way: each pallet, carton or other designated unit will show that the Product is “Processed” or the equivalent. Labels with
such markings will be provided by STERIS. 
 (f) After radiation processing, STERIS will return all cartons or other designated units to the
Customer’s address or to a controlled destination point selected by the Customer. 
 (g) Except as otherwise agreed by STERIS and
Customer, Products will be shipped in the same manner as received. 
 3. PROCESSING. 

(a) All Product processing will occur in accordance with a set of processing specifications (“Procedures”). Customer will develop
Procedures, which shall be in writing and shall clearly state minimum and maximum dose limitations, instructions regarding product counts, and handling, shipping, receiving, and special processing requirements. STERIS may accept or reject the
Procedures, but no processing will occur until STERIS and Customer agree in writing to the applicable Procedures. STERIS’s approval of the Procedures is limited to confirmation of its ability to process to the specifications and is not an
approval or determination of the efficacy of the dose which is solely the responsibility of Customer. 
 (b) Customer shall provide and
STERIS shall process Products in volumes summarized in Appendix A, “Processing Volumes,” which is hereby incorporated into this Agreement. If, at any time, STERIS determines that the demand for certain processing exceeds the supply, then
STERIS shall [*]. 
 (c) Customer shall bear sole responsibility for determining the compatibility of Products and packages with the
radiation process and for determining the radiation dosage(s). The Customer shall ship Product to STERIS in containers that are the same dimensions, weight, and internal packing configuration as qualified by STERIS. The Customer shall notify STERIS
of any changes to the Product, its materials, packaging or configuration. STERIS will not be responsible for non-sterile or damaged Product because of changes made to Products. All tests related to the
processing of the Products are the responsibility of Customer. 

  
 2 

[*] = Certain confidential information contained in this document, marked by brackets, is omitted because it is both (i) not material and (ii) would be
competitively harmful if publicly disclosed. 

 (d) After STERIS receives all required Products and documentation, STERIS will complete
processing within such time frame as agreed by the parties. 
 (e) STERIS will inform the Customer, in writing, of any changes or
modifications to the processing equipment which may impact routine processing or validation. STERIS will notify the Customer of deviations from the Procedures and the Customer will direct STERIS as to the disposition or reprocessing of those
affected Products. 
 (f) All tests related to assessing the final sterility assurance of the Products are solely the responsibility of the
Customer. Release of the sterilized Product to the market is the sole responsibility of the Customer. Customer shall develop appropriate procedures for approving the sterilized Products for release into the stream of commerce. Such procedures shall
be designed to prevent the release of any Product for commercial distribution until Customer’s designated representative shall properly approve the Product’s release. Customer bears ultimate and full responsibility for Products released
into commercial distribution, including labeling of Products as sterile. 
 (g) Except for Products sent to STERIS for test purposes (which
shall be clearly labeled “FOR TESTING PURPOSES ONLY”), the Customer warrants to STERIS that Products sent for services can be processed without violating any government regulations. 

4. TITLE TO PRODUCTS. Customer shall retain title to the Products at all times. 

5. AUDITS. STERIS will allow the Customer access to the Facilities, upon reasonable notice and subject to STERIS’s
restrictions of confidentiality, during normal business hours, for the purpose of conducting GMP/ISO/EN audits related to the processing of the Products. STERIS will also make training records available to Customer during such audits, provided
Customer requests such records reasonably in advance of the audit. STERIS will conduct periodic internal audits according to STERIS’s QSM/QA Manual. STERIS will retain confirmation that it performed these internal audits, and Customer may
review the confirmation upon reasonable prior notice. Customer shall keep confidential all information revealed to it during its audit of STERIS. The parties agree that notified bodies of the Customer are permitted to perform unannounced audits when
necessary. 
 6. TERM AND TERMINATION. The initial term of this Agreement shall be for a period of three (3) years from
the date of execution by both parties (the “Initial Term”). Thereafter, the Agreement shall automatically renew for one (1) year periods. Either party may, in its sole discretion, prevent the automatic renewal of this Agreement by
giving a written notice of termination to the other party no less than [*] prior to the expiration of the Initial Term or the then applicable renewal period. Either party shall have the right to terminate this Agreement at any time upon [*] written
notice if the other party is materially in default with respect to any of its obligations hereunder, and such default is not cured within [*] of notice to the defaulting party. 

7. RIGHT OF FIRST REFUSAL. Intentionally Omitted. 

8. REQUIREMENTS. Customer agrees that STERIS will perform 100% of the volume outlined in Appendix A pursuant to this Agreement,
of Customer’s radiation sterilization processing requirements during the term of the Agreement. Customer will use its best efforts to ensure that such processing will be requested of STERIS at a uniform monthly rate. 

  
 3 

[*] = Certain confidential information contained in this document, marked by brackets, is omitted because it is both (i) not material and (ii) would be
competitively harmful if publicly disclosed. 

 9. REMOVAL AND STORAGE; SHIPPING. 

(a) STERIS shall provide, at no extra charge to Customer, sufficient storage space for all processed Product for not more than [*] from
completion of processing. Thereafter, STERIS shall have the option of removing Customer’s Product via common carrier or other means to an alternate facility designated by Customer, or of charging Customer for storage for each day in excess of
the aforementioned [*]. 
 (b) The Customer shall pay all shipping costs. STERIS will not be responsible for any shipping damage or delay.

 10. CHARGES AND TERMS OF PAYMENT. 

(a) The charges for the processing of Customer’s Products pursuant to the Procedures are set forth in Appendix B, “Processing
Charges.” Customer shall have full and sole responsibility for all charges. Invoices will be rendered upon shipments made against a blanket order issued to STERIS by the Customer. Taxes, if applicable, are not included in the prices and shall
be paid by the Customer. 
 (b) Payments shall be due [*] from the date of invoice. All payments shall be made in United States dollars. Any
amount not paid when due shall bear interest at [*] or the highest lawful rate, if less, from the date due until paid. 
 11.
NOTICES. All communications related to the terms of this Agreement or communication seeking approval for changes in any procedures covered thereby shall be in writing and shall be personally delivered or sent by registered or certified
mail, postage prepaid, to the address indicated below, or to such other address as to the addressee shall have designated by notice given to the other party hereto, and shall be effective when received. 

 

					
	 If to STERIS:
	 		  	
			
	 Manager, Plant Operations
	 	cc:	  	Kenneth E. Kohler
	 Isomedix Operations Inc.
	 		  	Vice President and General Manager
	 3200 Lakeville Highway
	 		  	STERIS Applied Sterilization Technologies
	 Petaluma, California 94954
	 		  	5960 Heisley Road
		 		  	Mentor, Ohio 44060
			
	 Manager, Plant Operations
	 		  	
	 Isomedix Operations Inc.
	 		  	
	 9020 Activity Road, Suite D
	 		  	
	 San Diego, California 92126
	 		  	
			
	 If to Customer:
	 		  	
			
	 Elaine Lindsay
	 		  	
	 Intersect ENT 
	 		  	
	 1555 Adams Drive
	 		  	
	 Menlo Park, California 94025
	 		  	

  
 4 

[*] = Certain confidential information contained in this document, marked by brackets, is omitted because it is both (i) not material and (ii) would be
competitively harmful if publicly disclosed. 

 12. CONFIDENTIALITY; OWNERSHIP OF INTELLECTUAL PROPERTY. 

(a) The parties acknowledge and agree that in connection with the services provided under this Agreement valuable technical or marketing
information of a confidential nature may be exchanged by the parties; that such information will be retained by the receiving party in confidence; that the transmittal of such information by a disclosing party is upon the condition that the
information is to be used solely for the purpose of effectuating the Agreement; and that the receiving party shall not, either during the term of the Agreement or after its termination, use, publish, or disclose any technical or marketing
information supplied by the disclosing party. This restriction on disclosure and use shall not apply to any information which the receiving party can show by written evidence was known to it through proper means at the time of receipt thereof from
the disclosing party, or which may subsequently be obtained from sources other than the disclosing party who are not bound by a confidentiality agreement with Customer or STERIS. 

(b) The parties acknowledge and stipulate that the covenants and agreements contained herein are of a special nature and that any breach,
violation, or evasion by it of the restrictions of disclosure and use contained in this Agreement (i) may result in damages to the disclosing party in amounts difficult to ascertain; and (ii) may give rise to irreparable injury to the
disclosing party. Accordingly, the parties agree that the disclosing party has a right to sue and is entitled to equitable relief, including, without limitation, injunctive relief and specific performance, without the necessity of proof of actual
damage, against the actual or threatened breach, violation, or evasion of the Agreement by the receiving party in any proceeding that the disclosing party may bring to enforce any provision of this Agreement, in addition to any other legal remedies
that may be available. In the event of any breach, violation, or evasion of the restriction on disclosure and use contained in this Agreement, the disclosing party shall be entitled to recover reasonable legal fees and all costs and expenses
associated with the enforcement of any provision hereof or of the Agreement. 
 (c) STERIS shall retain all trademark, copyright, trade
secret, and patent rights which it may have with respect to the processing. Customer shall retain all trademark, copyright, trade secret, and patent rights it may have with respect to the Products. Neither party shall use the trademark or tradename
of the other party or its parents or affiliates in its company name or for otherwise conducting business with its customers. 
 13.
WARRANTY; LIMITATION OF LIABILITY; INSURANCE. 
 (a) STERIS warrants only that Products shall be processed in accordance with
Customer specifications, as accepted by STERIS. [*] EXCEPT AS SET FORTH ABOVE, STERIS MAKES NO REPRESENTATION OR WARRANTY OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING, WITHOUT LIMITATION, WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR
PURPOSE. 
 (b) STERIS SHALL NOT BE RESPONSIBLE FOR LOSS OF USE, LOSS OF INCOME OR PROFITS, COST OR RENTAL OF A SIMILAR PRODUCT, OR ANY
OTHER CONSEQUENTIAL OR INCIDENTAL DAMAGES OF ANY KIND WHATSOEVER, WHETHER DUE TO BREACH OF CONTRACT OR WARRANTY OR TORT, INCLUDING NEGLIGENCE OF STERIS OR STRICT LIABILITY, OR ANY OTHER CAUSE. In the event STERIS fails to process any Products as
agreed, or any Products are damaged or destroyed due to the fault of STERIS, [*]. However, if the Products [*] prior to processing and [*] related to such Products shall be [*]. Notwithstanding the foregoing, the parties acknowledge and agree that
[*] any loss or damage to Products that is caused by [*] and [*]. 

  
 5 

[*] = Certain confidential information contained in this document, marked by brackets, is omitted because it is both (i) not material and (ii) would be
competitively harmful if publicly disclosed. 

 (c) Customer shall carry an occurrence basis liability insurance policy with respect to the
processed Products. 
 14. INDEMNITY. Customer agrees to defend, indemnify, and hold harmless STERIS for any and all claims,
liability, damages or expenses due to personal injuries, including death, to employees of Customer, STERIS and to third parties, and for property damage, including damage to Customer Products, arising from Customer’s negligence, willful
misconduct or breach of contract, except to the extent caused by STERIS’s negligence or breach of contract. Subject to the Limitations of Liability set forth above, STERIS agrees to defend, indemnify, and hold harmless Customer for any and all
claims, liability, damages or expenses due to personal injuries, including death, to employees of Customer, STERIS and to third parties, and for property damage, including damage to Customer Products, arising from STERIS’s negligence or breach
of contract, except to the extent caused by Customer’s negligence or breach of contract. 
 15. MISCELLANEOUS. 

(a) If any provision of this Agreement shall be held invalid by a court of competent jurisdiction, such invalidity shall not affect any other
provision which can be given effect without the invalid provision. 
 (b) The delay or failure of either party to require performance by the
other party, or the waiver of a breach of any provision of this Agreement by either party, will not affect such party’s right to subsequently require performance of any provision of this Agreement. 

(c) The headings are inserted in the Agreement only as a matter of convenience and for reference and are not intended to define, limit, or
describe the scope of the Agreement nor the intent of any of its provisions. 
 (d) The Agreement represents the complete agreement,
understanding and obligation between the parties concerning its subject matter and supersedes all previous negotiations, representations, commitments and agreements, whether written, oral or implied, relating to its subject matter. No change,
amendment or modification of this Agreement shall be effective unless made in writing and signed by both parties. Any terms in Customer’s purchase order or any other document of order or acceptance which are different from or additional to this
Agreement shall be of no force and effect. No course of dealing, or custom or usage, which is contrary to this Agreement shall serve to modify the terms of this Agreement. 

(e) Neither party shall be liable for either its failure to perform or its delays in performance hereunder arising out of or resulting from
causes beyond its control. Such causes include but are not restricted to acts of God, acts of Government or the public enemy, fires, floods, epidemics, power disruptions, equipment failure, quarantine restrictions, strikes, freight embargoes,
unusually severe weather or default of suppliers due to any such causes. 

  
 6 

[*] = Certain confidential information contained in this document, marked by brackets, is omitted because it is both (i) not material and (ii) would be
competitively harmful if publicly disclosed. 

 (f) The relationship between the parties is that of vendor and independent contractor.
Neither the Customer nor any of its officers, directors, agents, or employees shall be considered as an agent or employee of STERIS. In performing obligations and accepting benefits under this Agreement, Customer acts on its own account and has no
authority or power to bind or to create any express or implied obligation on STERIS’s behalf. 
 (g) Neither party shall assign this
Agreement, or any of the rights or privileges contained in this Agreement, to any third party without the written consent of the other party which shall not be unreasonably withheld; provided, however, a party hereto may assign all or a portion of
its rights and delegate all or a portion of its duties under this Agreement in connection with a merger, acquisition, or a sale of all or substantially all of its assets to which this Agreement pertains. STERIS may assign its rights and duties
hereunder to an affiliate of STERIS. 
 (h) The Agreement and the relationship between the parties shall be governed by and interpreted in
accordance with the laws of the State of Delaware without regard to its conflicts-of-law principles. 

IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by their duly authorized representatives. 

 

									
	Isomedix Operations Inc.	 		 	Intersect ENT, Inc.
					
	By:	 	 /s/ Kenneth E. Kohler
	 		 	By:	 	 /s/ Lisa Earnhardt

		 	(Signature)	 		 		 	(Signature)
		 	Kenneth E. Kohler	 		 		 	Lisa Earnhardt
		 	(Print Name)	 		 		 	(Print Name)
	 Title:  VP and General Manager, STERIS Applied Sterilization
Technologies
	 		 	Title: President and CEO
			
	Date: 02/01/2019	 		 	Date: 1/14/19

  
 7 

[*] = Certain confidential information contained in this document, marked by brackets, is omitted because it is both (i) not material and (ii) would be
competitively harmful if publicly disclosed. 

 APPENDIX A 

PROCESSING VOLUMES 
 Customer
Requirements 
  

	 	•	 	 [*] 

  

	 	•	 	 [*] 

  
 8 

[*] = Certain confidential information contained in this document, marked by brackets, is omitted because it is both (i) not material and (ii) would be
competitively harmful if publicly disclosed. 

 APPENDIX B 

PROCESSING CHARGES 

Electron Radiation Processing 

Electron Radiation Processing – Petaluma and San Diego Facility 
  

	 	•	 	 [*] 

Radiation Processing, Reference Mapping, Dose Validation and Dose Audit Charges 

 

	 	•	 	 Pricing available upon request from the STERIS Radiation Tech Center. 

Processing Optional Services and other Ancillary Charges 
  

	 	•	 	 These prices are available upon request. 

On the first anniversary date of this Agreement, and on each anniversary date thereafter, STERIS shall have the right to increase the processing charges [*].

 Pricing is dependent on the processing parameters set forth above and the anticipated volumes set forth in Appendix A. In the event the processing
parameters change or volumes are not consistent with Appendix A, STERIS may request a price adjustment, which shall not be unreasonably withheld. 

  
 9 

[*] = Certain confidential information contained in this document, marked by brackets, is omitted because it is both (i) not material and (ii) would be
competitively harmful if publicly disclosed.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00295-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00295-of-00352.parquet"}]]